Clinical observations with Péflacine.
The results of our study prove--incongruency with data in references--that pefloxacin, Pèflacine (EGIS-Rhône-Poulenc-Rorer) can be successfully used in the treatment of severe, medium severity infections acquired in hospitals. Our observations refer to urinary tract, hepatic-biliary tract, and lower respiratory tract infections. Differences were not found between the effectivity of oral and intravenous drug doses. Side-effects were observed in a relatively low number of cases, in 10% of the patients. On the basis of our observations pefloxacin seems to be an effective drug which can be used safely.
Department A of Medicine, Hospital Municipal Pèterfy Sándor.
E
E
Ludwig
E
E
Székely
M
M
Arr
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D003428:Cross Infection / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D015366:Pefloxacin / Q000627:therapeutic use*; D011446:Prospective Studies; D016896:Treatment Outcome
D015366:Pefloxacin